Institution
University of Louisville
Education•Louisville, Kentucky, United States•
About: University of Louisville is a education organization based out in Louisville, Kentucky, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 24600 authors who have published 49248 publications receiving 1573346 citations. The organization is also known as: UofL.
Topics: Population, Poison control, Transplantation, Stem cell, Breast cancer
Papers published on a yearly basis
Papers
More filters
••
TL;DR: It is concluded that the main focus of the HFE discipline in the 21st century will be the design and management of systems that satisfy human compatibility requirements.
Abstract: This paper provides a theoretical perspective on human factors and ergonomics (HFE), defined as a unique and independent discipline that focuses on the nature of human-artefact interactions, viewed from the unified perspective of the science, engineering, design, technology and management of human-compatible systems. Such systems include a variety of natural and artificial products, processes and living environments. The distinguishing features of the contemporary HFE discipline and profession are discussed and a concept of ergonomics literacy is proposed. An axiomatic approach to ergonomics design and a universal measure of system-human incompatibility are also introduced. It is concluded that the main focus of the HFE discipline in the 21st century will be the design and management of systems that satisfy human compatibility requirements.
280 citations
••
TL;DR: The meibomian gland's contribution to TF lipids and lipid-binding proteins and lipid–protein interactions in health and disease are examined to examine their relationship with disease and TF stability.
Abstract: Understanding the molecular composition (e.g., proteins and lipids) of the tear film (TF) and the contribution of the meibomian gland to the TF is critical in gaining knowledge about TF instabilities, dry eye syndromes, contact lens (CL) incompatibilities, and other eye diseases. Among its functions, the lipid layer of the TF slows evaporation of the aqueous component, preserves a clear optical surface, and forms a barrier to protect the eye from microbial agents and organic matter, such as dust and pollen.1 The TF contains a complex mixture of proteins, enzymes, lipids, mucins, and salts that allows the TF to perform its functions (Fig. 1). Researchers believe the outer lipid layer is 5 to 10 molecules thick and is composed primarily of wax and sterol esters, possibly intercalated with each other and with proteins rather than forming distinct repeating layers of molecules.2,3 Evidence from interferometric studies indicate that the TF lipid layer thickness ranges from 20 to 160 nm.4 If the size of a lipid molecule is approximately 2.2 nm (22 Å), then the calculated thickness for one layer would be 11 to 44 nm. The addition of polar and nonpolar layers would add to the lipid thickness, which indicates that the lipid component of the TF may be multiple layers thick or have other contributing sources to correspond with reported thickness measurements.5
Figure 1.
A proposed model of the precorneal tear film showing the relationship and interaction of lipid-binding proteins and the outer lipid layer.
While the signs and symptoms of TF instability are reasonably well characterized, we are only beginning to understand the specific molecular components of the TF and their relationship with disease and TF stability. The purpose of this review is to examine the meibomian gland's contribution to TF lipids and lipid–protein interactions in health and disease.
280 citations
••
TL;DR: This review separates the methods into vapor-phase synthesis, solution- phase synthesis, template-based synthesis, and other approaches, such as lithography, electrospinning, and assembly, used to form a variety of heterojunctions from different combinations of semiconductor, metal, carbon, and polymeric materials.
Abstract: There are a variety of methods for synthesizing or fabricating one-dimensional (1D) nanostructures containing heterojunctions between different materials. Here we review recent developments in the synthesis and fabrication of heterojunctions formed between different materials within the same 1D nanostructure or between different 1D nanostructures composed of different materials. Structures containing 1D nanoscale heterojunctions exhibit interesting chemistry as well as size, shape, and material-dependent properties that are unique when compared to single-component materials. This leads to new or enhanced properties or multifunctionality useful for a variety of applications in electronics, photonics, catalysis, and sensing, for example. This review separates the methods into vapor-phase synthesis, solution-phase synthesis, template-based synthesis, and other approaches, such as lithography, electrospinning, and assembly. These methods are used to form a variety of heterojunctions, including segmented, core/shell, branched, or crossed, from different combinations of semiconductor, metal, carbon, and polymeric materials.
279 citations
••
TL;DR: Evidence is presented that supports prosurvival activity of ERK1/2 in neurons that mediates neuroprotective activity of extracellular factors, including neurotrophins.
Abstract: Extracellular signal regulated kinases 1 and 2 (ERK1/2) regulate cellular responses to a variety of extracellular stimuli. In the nervous system, ERK1/2 is critical for neuronal differentiation, plasticity and may also modulate neuronal survival. In this minireview, we present evidence that supports prosurvival activity of ERK1/2 in neurons. Several reports suggest that ERK1/2 mediates neuroprotective activity of extracellular factors, including neurotrophins. In addition, ERK1/2 is activated by neuronal injury. In damaged cells, ERK1/2 activation may act as a defensive mechanism that helps to compensate for the deleterious effects of a damaging insult. The emerging mechanisms of ERK1/2-mediated neuroprotection may involve transcriptional regulation and/or direct inhibition of cell death machinery.
278 citations
••
University of Texas MD Anderson Cancer Center1, Hoffmann-La Roche2, University of Basel3, Aalborg University4, Memorial Sloan Kettering Cancer Center5, Cornell University6, Houston Methodist Hospital7, Columbia University8, University of North Carolina at Chapel Hill9, Cleveland Clinic10, University of Maryland, Baltimore11, University of Hong Kong12, Zhejiang University13, Radboud University Nijmegen14, City of Hope National Medical Center15, University of Ulsan16, University of California, San Francisco17, Southwest Washington Medical Center18, University of Wisconsin-Madison19, Northwestern University20, Nanjing Medical University21, University of Louisville22, University of Southern Denmark23
TL;DR: Assessment of TP53 mutation status is important for stratifying R-CHOP-treated patients into distinct prognostic subsets and has significant value in the design of future therapeutic strategies.
278 citations
Authors
Showing all 24802 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert M. Califf | 196 | 1561 | 167961 |
Aaron R. Folsom | 181 | 1118 | 134044 |
Yang Gao | 168 | 2047 | 146301 |
Stephen J. O'Brien | 153 | 1062 | 93025 |
James J. Collins | 151 | 669 | 89476 |
Anthony E. Lang | 149 | 1028 | 95630 |
Sw. Banerjee | 146 | 1906 | 124364 |
Hermann Kolanoski | 145 | 1279 | 96152 |
Ferenc A. Jolesz | 143 | 631 | 66198 |
Daniel S. Berman | 141 | 1363 | 86136 |
Aaron T. Beck | 139 | 536 | 170816 |
Kevin J. Tracey | 138 | 561 | 82791 |
C. Dallapiccola | 136 | 1717 | 101947 |
Michael I. Posner | 134 | 414 | 104201 |
Alan Sher | 132 | 486 | 68128 |